Junyelt (Copper Gluconate, Manganese Gluconate, Potassium Iodide, Sodium Selenite, Zinc Gluconate)

Each element serves as a cofactor for specific enzymes and physiological pathways. Copper and manganese support oxidative‑stress enzymes, zinc is vital for immune function and DNA synthesis, iodine is required for thyroid hormone production, and selenium forms part of antioxidant enzymes such as glutathione peroxidase. Together they help maintain metabolic balance and cellular protection.

The dose of Junyelt is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and laboratory‑measured trace‑element levels. The healthcare professional will calculate the appropriate volume and infusion rate to safely meet the individual’s nutritional needs.

Junyelt should only be used in pregnancy or lactation when the potential benefit justifies any possible risk to the fetus or infant. The decision rests with the treating physician, who will consider the mother’s trace‑element status and the clinical necessity of intravenous supplementation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed) and any required import documentation.

Junyelt combines five essential trace elements in a single sterile IV formulation, reducing the need for multiple separate infusions. Compared with single‑element products, it offers convenience and may improve compliance in settings where rapid, comprehensive micronutrient repletion is required, while maintaining comparable safety profiles.

Junyelt must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken. Before administration, inspect the solution for particulate matter or discoloration and use aseptic technique to avoid contamination.

Junyelt is given intravenously, typically as an infusion added to a compatible carrier fluid. The exact infusion rate and duration are set by the prescribing clinician, who will also monitor the patient’s vital signs and laboratory values during and after the administration.

Serious risks include anaphylactic reactions, copper overload (hypercupremia), selenium toxicity (selenosis), and iodine‑related thyroid dysfunction. Prompt recognition of symptoms such as difficulty breathing, rash, unexplained hepatic changes, or thyroid hormone abnormalities is essential, and immediate medical intervention should be initiated.

Junyelt is contraindicated in patients with known hypersensitivity to any of its components. Caution is also advised for individuals with severe renal impairment, uncontrolled thyroid disease, or those already receiving high‑dose oral or parenteral supplements of the same trace elements, unless closely supervised by a specialist.